We are live on ! Find out more
IMMU

Immunomedics Inc
IMMU

Delisted

IMMU was delisted on the 22nd of October, 2020.

Back to rankings

168 hedge funds and large institutions have $1.83B invested in Immunomedics Inc in 2018 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 61 increasing their positions, 55 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 16

11% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 55

7% more funds holding

Funds holding: 157 → 168 (+11)

8% more call options, than puts

Call options by funds: $88M | Put options by funds: $81.2M

8% less capital invested

Capital invested by funds: $1.99B → $1.83B (-$158M)

11% less funds holding in top 10

Funds holding in top 10: 9 → 8 (-1)

Holders
168
Holders Change
+11
Holders Change %
+7.01%
% of All Funds
3.85%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.18%
New
28
Increased
61
Reduced
55
Closed
16
Calls
$88M
Puts
$81.2M
Net Calls
+$6.82M
Net Calls Change
-$77.3M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$52M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$49.2M
3
ACA
Avoro Capital Advisors
New York
+$14.3M
4
Norges Bank
Norges Bank
Norway
+$14.3M
5
Capital World Investors
Capital World Investors
California
+$12.8M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$57.1M
2
O
OrbiMed
New York
-$44.9M
3
Citadel Advisors
Citadel Advisors
Florida
-$42.7M
4
ACP
Acuta Capital Partners
California
-$14.7M
5
OM
Opaleye Management
Massachusetts
-$14.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
AllianceBernstein
51
AllianceBernstein
Tennessee
$4.42M +$2.5M +153,200 +102%
DCM
52
DAFNA Capital Management
California
$4.1M -$377K -23,100 -8%
SSA
53
Schonfeld Strategic Advisors
New York
$3.95M +$806K +49,346 +22%
AAP
54
Ardsley Advisory Partners
Connecticut
$3.87M +$654K +40,000 +18%
LSC
55
Lyon Street Capital
California
$3.69M -$3.17M -193,848 -43%
TCIM
56
TIAA CREF Investment Management
New York
$3.67M +$5.92K +362 +0.1%
Citigroup
57
Citigroup
New York
$3.32M -$4.29M -262,385 -54%
AA
58
ALPS Advisors
Colorado
$3.25M +$881K +53,897 +32%
TA
59
Teachers Advisors
New York
$3.09M – – –
Swiss National Bank
60
Swiss National Bank
Switzerland
$3.09M +$899K +55,000 +35%
Creative Planning
61
Creative Planning
Kansas
$2.99M -$139K -8,514 -4%
UBS Group
62
UBS Group
Switzerland
$2.77M -$2.79M -170,740 -47%
GC
63
Guggenheim Capital
Illinois
$2.71M -$326K -19,965 -10%
TD Asset Management
64
TD Asset Management
Ontario, Canada
$2.5M +$199K +12,200 +8%
UONDDL
65
University of Notre Dame du Lac
Indiana
$2.44M +$2.73M +167,038 New
MWNA
66
Marshall Wace North America
New York
$2.29M -$5.26M -321,946 -67%
Royal Bank of Canada
67
Royal Bank of Canada
Ontario, Canada
$2.28M +$2.5M +152,941 +4,518%
California State Teachers Retirement System (CalSTRS)
68
California State Teachers Retirement System (CalSTRS)
California
$2.27M -$89.2K -5,457 -3%
California Public Employees Retirement System
69
California Public Employees Retirement System
California
$2.26M -$354K -21,694 -12%
SW
70
SVB Wealth
Massachusetts
$2.12M – – –
D.E. Shaw & Co
71
D.E. Shaw & Co
New York
$2.09M +$1.63M +99,563 +229%
GIM
72
Granahan Investment Management
Massachusetts
$2.04M – – –
New York State Common Retirement Fund
73
New York State Common Retirement Fund
New York
$2.02M – – –
FAM
74
Fred Alger Management
New York
$2.01M +$1.35M +82,549 +150%
NFG
75
Next Financial Group
Texas
$1.83M +$68.6K +4,200 +3%
1 2
3
4 5

IMMU Hedge Fund Activity: Q1 2018 in Review

168 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q1 2018, worth a combined $1.83B — down 7.9% from $1.99B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new IMMU positions and 16 closed out — a net gain of 12 holders — while 61 added to existing stakes and 55 trimmed.

The largest buyer was Vanguard Group, adding an estimated $52M. The largest seller was Millennium Management, cutting an estimated $57.1M.

  • 168 institutional investors held Immunomedics Inc (IMMU) as of Q1 2018, up from 157 in Q4 2017.
  • Funds reported $1.83B of Immunomedics Inc stock for Q1 2018, down 7.9% quarter-over-quarter.
  • 28 funds opened new Immunomedics Inc positions in Q1 2018 and 16 closed out, a net change of +12 holders.
  • The largest Immunomedics Inc buyer in Q1 2018 was Vanguard Group, an estimated $52M added.
  • The largest Immunomedics Inc seller in Q1 2018 was Millennium Management, an estimated $57.1M sold.

Based on aggregated 13F filings for Q1 2018.